Journal
NATURE GENETICS
Volume 42, Issue 5, Pages 392-U45Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ng.557
Keywords
-
Categories
Funding
- ALS
- Muscular Dystrophy Association/Augie's Quest
- US Department of Defense
- RGK Foundation
Ask authors/readers for more resources
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive loss of motor neurons. Using unbiased transcript profiling in an ALS mouse model, we identified a role for the co-stimulatory pathway, a key regulator of immune responses. Furthermore, we observed that this pathway is upregulated in the blood of 56% of human patients with ALS. A therapy using a monoclonal antibody to CD40L was developed that slows weight loss, delays paralysis and extends survival in an ALS mouse model. This work demonstrates that unbiased transcript profiling can identify cellular pathways responsive to therapeutic intervention in a preclinical model of human disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available